In vivo estimation of midline dose maps by transit dosimetry in head and neck radiotherapy

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The aim of the present study is to compare the calculated midline dose map with the in vivo measured midline dose map, using portal detectors in conjunction with a pair of diodes. Measurements were performed in 10 patients treated for head/neck cancer and irradiated with lateral opposed 6 MV X-ray beams. The relative exit dose map, derived from transmission dose data of a portal film combined with the absolute entrance/exit dose measured by the diodes, can be used to derive the corresponding midline dose map by applying appropriate algorithms. Midplane dose values were estimated in eight relevant anatomic positions and compared with the corresponding calculated values with our three-dimensional (3D) treatment planning system using two-dimensional (2D) (Batho) and 3D (ETAR) inhomogeneity correction algorithms. In vivo estimated midplane doses agree within ±3.5% relative to treatment planning calculations in 89 of 116 measurements points, with only 4 of 116 points outside ±5%. A variation between measured and calculated dose can be found according to anatomical location. For air inhomogeneity, mean deviations were +2.2% (1 standard deviation (SD)≈1.7%) for both Batho and ETAR algorithms; for bone structures, mean deviations were approximately -0.6% (1 SD≈2.7%) for both algorithms. The worst agreement was found in the anterior neck where the mean deviation between measured and calculated midline dose was +3.1% (1 SD=1.4%) and +3.4% (1 SD= 2%) using Batho and ETAR, respectively. Sufficiently accurate 2D midplane dose maps may be simply obtained in vivo in the irradiation of head/neck cancer by using a portal detector in combination with a pair of diodes, in order to verify the dose actually delivered during treatment.

Original languageEnglish
Pages (from-to)974-981
Number of pages8
JournalBritish Journal of Radiology
Volume75
Issue number900
Publication statusPublished - Dec 1 2002

Fingerprint

Neck
Radiotherapy
Head
Head and Neck Neoplasms
Air
X-Rays
Bone and Bones
Therapeutics

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

In vivo estimation of midline dose maps by transit dosimetry in head and neck radiotherapy. / Broggi, Sara; Fiorino, C.; Calandrino, R.

In: British Journal of Radiology, Vol. 75, No. 900, 01.12.2002, p. 974-981.

Research output: Contribution to journalArticle

@article{129ad267e7c5414e91e5dfd3e322cd92,
title = "In vivo estimation of midline dose maps by transit dosimetry in head and neck radiotherapy",
abstract = "The aim of the present study is to compare the calculated midline dose map with the in vivo measured midline dose map, using portal detectors in conjunction with a pair of diodes. Measurements were performed in 10 patients treated for head/neck cancer and irradiated with lateral opposed 6 MV X-ray beams. The relative exit dose map, derived from transmission dose data of a portal film combined with the absolute entrance/exit dose measured by the diodes, can be used to derive the corresponding midline dose map by applying appropriate algorithms. Midplane dose values were estimated in eight relevant anatomic positions and compared with the corresponding calculated values with our three-dimensional (3D) treatment planning system using two-dimensional (2D) (Batho) and 3D (ETAR) inhomogeneity correction algorithms. In vivo estimated midplane doses agree within ±3.5{\%} relative to treatment planning calculations in 89 of 116 measurements points, with only 4 of 116 points outside ±5{\%}. A variation between measured and calculated dose can be found according to anatomical location. For air inhomogeneity, mean deviations were +2.2{\%} (1 standard deviation (SD)≈1.7{\%}) for both Batho and ETAR algorithms; for bone structures, mean deviations were approximately -0.6{\%} (1 SD≈2.7{\%}) for both algorithms. The worst agreement was found in the anterior neck where the mean deviation between measured and calculated midline dose was +3.1{\%} (1 SD=1.4{\%}) and +3.4{\%} (1 SD= 2{\%}) using Batho and ETAR, respectively. Sufficiently accurate 2D midplane dose maps may be simply obtained in vivo in the irradiation of head/neck cancer by using a portal detector in combination with a pair of diodes, in order to verify the dose actually delivered during treatment.",
author = "Sara Broggi and C. Fiorino and R. Calandrino",
year = "2002",
month = "12",
day = "1",
language = "English",
volume = "75",
pages = "974--981",
journal = "British Journal of Radiology",
issn = "0007-1285",
publisher = "British Institute of Radiology",
number = "900",

}

TY - JOUR

T1 - In vivo estimation of midline dose maps by transit dosimetry in head and neck radiotherapy

AU - Broggi, Sara

AU - Fiorino, C.

AU - Calandrino, R.

PY - 2002/12/1

Y1 - 2002/12/1

N2 - The aim of the present study is to compare the calculated midline dose map with the in vivo measured midline dose map, using portal detectors in conjunction with a pair of diodes. Measurements were performed in 10 patients treated for head/neck cancer and irradiated with lateral opposed 6 MV X-ray beams. The relative exit dose map, derived from transmission dose data of a portal film combined with the absolute entrance/exit dose measured by the diodes, can be used to derive the corresponding midline dose map by applying appropriate algorithms. Midplane dose values were estimated in eight relevant anatomic positions and compared with the corresponding calculated values with our three-dimensional (3D) treatment planning system using two-dimensional (2D) (Batho) and 3D (ETAR) inhomogeneity correction algorithms. In vivo estimated midplane doses agree within ±3.5% relative to treatment planning calculations in 89 of 116 measurements points, with only 4 of 116 points outside ±5%. A variation between measured and calculated dose can be found according to anatomical location. For air inhomogeneity, mean deviations were +2.2% (1 standard deviation (SD)≈1.7%) for both Batho and ETAR algorithms; for bone structures, mean deviations were approximately -0.6% (1 SD≈2.7%) for both algorithms. The worst agreement was found in the anterior neck where the mean deviation between measured and calculated midline dose was +3.1% (1 SD=1.4%) and +3.4% (1 SD= 2%) using Batho and ETAR, respectively. Sufficiently accurate 2D midplane dose maps may be simply obtained in vivo in the irradiation of head/neck cancer by using a portal detector in combination with a pair of diodes, in order to verify the dose actually delivered during treatment.

AB - The aim of the present study is to compare the calculated midline dose map with the in vivo measured midline dose map, using portal detectors in conjunction with a pair of diodes. Measurements were performed in 10 patients treated for head/neck cancer and irradiated with lateral opposed 6 MV X-ray beams. The relative exit dose map, derived from transmission dose data of a portal film combined with the absolute entrance/exit dose measured by the diodes, can be used to derive the corresponding midline dose map by applying appropriate algorithms. Midplane dose values were estimated in eight relevant anatomic positions and compared with the corresponding calculated values with our three-dimensional (3D) treatment planning system using two-dimensional (2D) (Batho) and 3D (ETAR) inhomogeneity correction algorithms. In vivo estimated midplane doses agree within ±3.5% relative to treatment planning calculations in 89 of 116 measurements points, with only 4 of 116 points outside ±5%. A variation between measured and calculated dose can be found according to anatomical location. For air inhomogeneity, mean deviations were +2.2% (1 standard deviation (SD)≈1.7%) for both Batho and ETAR algorithms; for bone structures, mean deviations were approximately -0.6% (1 SD≈2.7%) for both algorithms. The worst agreement was found in the anterior neck where the mean deviation between measured and calculated midline dose was +3.1% (1 SD=1.4%) and +3.4% (1 SD= 2%) using Batho and ETAR, respectively. Sufficiently accurate 2D midplane dose maps may be simply obtained in vivo in the irradiation of head/neck cancer by using a portal detector in combination with a pair of diodes, in order to verify the dose actually delivered during treatment.

UR - http://www.scopus.com/inward/record.url?scp=0036971275&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036971275&partnerID=8YFLogxK

M3 - Article

C2 - 12515706

AN - SCOPUS:0036971275

VL - 75

SP - 974

EP - 981

JO - British Journal of Radiology

JF - British Journal of Radiology

SN - 0007-1285

IS - 900

ER -